Feedback / Questions
Kisqali (ribociclib) - Novartis
Kisqali: OS data from P3 MONALEESA-2 trial (NCT01958021) for postmenopausal women with advanced breast cancer in H2 2020
(Novartis)
-
Jan 29, 2020 -
Q4 and FY 2019 Results
P3 data
https://www.novartis.com/sites/www.novartis.com/files/q4-2019-investor-presentation.pdf
Jan 29, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious